Doubts rise over Ottawa's ability to implement universal drug coverage if pharmacare bill passes

Many experts point to a high-profile public campaign to bring a new cystic fibrosis drug to Canada as the pivotal event that led to the eventual unravelling of price reforms

Related Keywords

United Kingdom ,Toronto ,Ontario ,Canada ,Dalhousie ,New Brunswick ,British ,Canadian ,Kelly Grover ,Danyaal Raza ,Steve Morgan ,Thomas Digby ,Jean Yves Duclos ,Michael Siauw ,Jane Philpott ,Sharon Batt ,Prabh Grewal ,Public Health ,University Of British Columbia School Population ,Vertex Pharmaceuticals ,Health Canada ,Queen University ,Canadian Institute For Health Information ,Dalhousie University In Halifax ,University Of Toronto ,Log Increate Free ,Patented Medicine Prices Review Board ,Cystic Fibrosis Canada ,Boston Based Vertex Pharmaceuticals ,Cystic Fibrosis ,Anie Perrault ,Dalhousie University ,Canadian Institute ,British Columbia ,Drug ,Pmprb ,Industry ,Vertex ,Government ,Trikafta ,Queen X27s University ,Halifax ,